Trio-Tech International TRT Short-term restricted investments

Short-term restricted investments at other companies

UroGen PharmaURGN

$177K+0.6%

Intercontinental ExchangeICE

$884M+43.3%

VAL

Value LineVALU

$305K0.0%

UFP Industries, Inc.UFPI

$51.3M+22.0%

IngevityNGVT

$24.7M—

DocGoDCGO

$13.12M—

Other financials

Income statement

See full

Revenue$16.5M+124%

Net income-$37.0K+92.2%

Balance sheet

See full

Cash & equivalents$13.0M+17.7%

Total debt$3.1M+87.4%

Total equity$34.3M+6.2%

Total assets$44.7M+11.9%

Cash flow

See full

Operating cash flow$1.3M+60.2%

CapEx$544.0K+249%

Free cash flow$707.0K+13.1%

Valuation

See full

Market cap$104.97M+343%

Enterprise value$95.13M+570%

P/E178.2×-277×

P/S1.8×+1.1×

Profitability

See full

Gross margin23.6%—

Operating margin-1.8%—

Net margin1%+0.7pp

FCF margin5.3%+4.0pp

Returns & leverage

See full

Return on equity1.8%+1.4pp

Debt / equity0.1×0.0×

Current ratio3.4×-1.5×

Where this comes from

Reported directly by Trio-Tech International in its filing.

Tagged under the XBRL concept us-gaap:RestrictedInvestmentsCurrent.

The official record: Trio-Tech International’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Trio-Tech International's short-term restricted investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Trio-Tech International's short-term restricted investments?: Trio-Tech International (TRT) reported short-term restricted investments of $821K in Q1 2026.
How has Trio-Tech International's short-term restricted investments changed year-over-year?: Trio-Tech International's short-term restricted investments increased by 5.8% year-over-year, from $776K to $821K.